Getinge AB Class B GNGBF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $19.56
- Day Range
- $19.71–19.71
- 52-Week Range
- $16.76–24.84
- Bid/Ask
- $17.97 / $20.06
- Market Cap
- $5.37 Bil
- Volume/Avg
- 100 / 237
Key Statistics
- Price/Earnings (Normalized)
- 22.80
- Price/Sales
- 1.79
- Dividend Yield (Trailing)
- 21.57%
- Dividend Yield (Forward)
- 2.14%
- Total Yield
- 21.57%
Company Profile
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Core
- Total Number of Employees
- 11,739
- Website
- https://www.getinge.com
Competitors
Valuation
|
Metric
|
GNGBF
|
MDT
|
TFX
|
|---|---|---|---|
Price/Earnings (Normalized) | 22.80 | 14.64 | 15.18 |
Price/Book Value | 1.78 | 2.03 | 2.20 |
Price/Sales | 1.79 | 3.26 | 3.30 |
Price/Cash Flow | 12.41 | 14.42 | 15.73 |
Price/Earnings
GNGBF
MDT
TFX
Financial Strength
|
Metric
|
GNGBF
|
MDT
|
TFX
|
|---|---|---|---|
Quick Ratio | 0.75 | 1.46 | 1.10 |
Current Ratio | 1.26 | 2.30 | 2.32 |
Interest Coverage | 7.87 | 8.86 | 5.95 |
Quick Ratio
GNGBF
MDT
TFX
Profitability
|
Metric
|
GNGBF
|
MDT
|
TFX
|
|---|---|---|---|
Return on Assets (Normalized) | 4.79% | 7.75% | 5.96% |
Return on Equity (Normalized) | 8.20% | 13.75% | 10.10% |
Return on Invested Capital (Normalized) | 7.34% | 9.87% | 7.98% |
Return on Assets
GNGBF
MDT
TFX
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Wrmrhsbgy | Nqwgnd | $182.7 Bil | |
SYK
| Stryker Corp | Shptgwnhsf | Spztj | $124.6 Bil | |
MDT
| Medtronic PLC | Nbhncjhd | Bxzxb | $105.2 Bil | |
BSX
| Boston Scientific Corp | Xnnwyqfm | Gnyyfvr | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Hjvvjfpgf | Flvkzmd | $52.0 Bil | |
DXCM
| DexCom Inc | Tyjdchrjcf | Nlkwm | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Jbfccktjby | Hjp | $24.5 Bil | |
ALGN
| Align Technology Inc | Kyplbzym | Hpbsm | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Slvjrdtt | Cjwmx | $18.3 Bil | |
PODD
| Insulet Corp | Dbmvlzfpl | Nwhnc | $11.6 Bil |